Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Proteins | 3 | 2000 | 297 | 0.460 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2015 | 2903 | 0.360 |
Why?
|
| Serpins | 2 | 2000 | 72 | 0.340 |
Why?
|
| Bone Marrow | 2 | 2007 | 2440 | 0.330 |
Why?
|
| Blood Platelet Disorders | 1 | 2009 | 35 | 0.320 |
Why?
|
| Protease Inhibitors | 2 | 1999 | 207 | 0.300 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2007 | 4 | 0.290 |
Why?
|
| Giant Cell Tumors | 1 | 2007 | 33 | 0.280 |
Why?
|
| Dermatofibrosarcoma | 1 | 2007 | 73 | 0.270 |
Why?
|
| Leukemia, Lymphoid | 1 | 2007 | 289 | 0.270 |
Why?
|
| Polyps | 1 | 2007 | 81 | 0.270 |
Why?
|
| Aspergillosis | 1 | 2007 | 248 | 0.250 |
Why?
|
| Factor Xa Inhibitors | 3 | 2000 | 73 | 0.250 |
Why?
|
| Vulvar Neoplasms | 1 | 2007 | 235 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2006 | 197 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2006 | 275 | 0.240 |
Why?
|
| Clone Cells | 1 | 2006 | 590 | 0.230 |
Why?
|
| Iron | 1 | 2007 | 380 | 0.230 |
Why?
|
| Stromal Cells | 1 | 2007 | 823 | 0.220 |
Why?
|
| E-Selectin | 1 | 2023 | 106 | 0.210 |
Why?
|
| Blast Crisis | 1 | 2006 | 588 | 0.210 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 513 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 2617 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2023 | 4965 | 0.170 |
Why?
|
| Carotid Artery Injuries | 1 | 1999 | 50 | 0.170 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 10714 | 0.170 |
Why?
|
| Immunoglobulins | 1 | 2020 | 292 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 3435 | 0.160 |
Why?
|
| Philadelphia Chromosome | 2 | 2018 | 852 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1388 | 0.160 |
Why?
|
| Lipoproteins | 1 | 1999 | 229 | 0.150 |
Why?
|
| Angioplasty, Balloon | 1 | 1999 | 176 | 0.150 |
Why?
|
| Longevity | 1 | 2019 | 155 | 0.150 |
Why?
|
| Myeloproliferative Disorders | 1 | 2006 | 882 | 0.150 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 2636 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2020 | 586 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 1999 | 293 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 537 | 0.140 |
Why?
|
| Tankyrases | 1 | 2015 | 9 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2007 | 1956 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2023 | 7273 | 0.130 |
Why?
|
| Blood Coagulation | 2 | 2009 | 167 | 0.120 |
Why?
|
| SMN Complex Proteins | 1 | 2014 | 10 | 0.120 |
Why?
|
| Coiled Bodies | 1 | 2014 | 8 | 0.120 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2014 | 35 | 0.120 |
Why?
|
| Chromatin | 1 | 2019 | 1044 | 0.110 |
Why?
|
| Proteolysis | 1 | 2015 | 378 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 310 | 0.110 |
Why?
|
| Imatinib Mesylate | 2 | 2009 | 1691 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 4838 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 659 | 0.100 |
Why?
|
| Benzamides | 2 | 2009 | 1879 | 0.100 |
Why?
|
| Cell Survival | 2 | 2015 | 3058 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1130 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2013 | 1251 | 0.090 |
Why?
|
| Factor Xa | 2 | 2000 | 23 | 0.090 |
Why?
|
| Telomerase | 1 | 2013 | 544 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2015 | 1145 | 0.080 |
Why?
|
| Chromosome Aberrations | 2 | 2007 | 2035 | 0.080 |
Why?
|
| Leukemia | 1 | 2018 | 1719 | 0.080 |
Why?
|
| Health | 1 | 2009 | 51 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2007 | 7046 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 597 | 0.080 |
Why?
|
| Phospholipids | 2 | 2000 | 167 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 1462 | 0.080 |
Why?
|
| Platelet Aggregation | 1 | 2009 | 180 | 0.080 |
Why?
|
| Piperazines | 2 | 2009 | 2145 | 0.080 |
Why?
|
| Cricetinae | 2 | 1999 | 762 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2013 | 1739 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 1942 | 0.080 |
Why?
|
| Humans | 18 | 2023 | 271093 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2013 | 2135 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 1456 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 442 | 0.070 |
Why?
|
| Adult | 8 | 2018 | 82174 | 0.060 |
Why?
|
| Dasatinib | 1 | 2009 | 881 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 5143 | 0.060 |
Why?
|
| Thiazoles | 1 | 2009 | 727 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2009 | 3671 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2015 | 2923 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2015 | 7232 | 0.060 |
Why?
|
| RNA Interference | 3 | 2015 | 1379 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2018 | 3155 | 0.060 |
Why?
|
| Adolescent | 4 | 2018 | 32784 | 0.060 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2010 | 750 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 2990 | 0.060 |
Why?
|
| Mutation | 5 | 2023 | 15904 | 0.060 |
Why?
|
| Calcium | 2 | 2000 | 1572 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2007 | 2317 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 525 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 4542 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 590 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 2112 | 0.050 |
Why?
|
| Aged | 6 | 2018 | 73550 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 966 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2023 | 276 | 0.050 |
Why?
|
| Prothrombin | 1 | 2000 | 36 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5417 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 3047 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2020 | 34 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 1008 | 0.040 |
Why?
|
| Rats | 2 | 1999 | 6404 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2023 | 12044 | 0.040 |
Why?
|
| Middle Aged | 6 | 2018 | 90524 | 0.040 |
Why?
|
| Thrombin | 1 | 2000 | 91 | 0.040 |
Why?
|
| Female | 8 | 2020 | 149120 | 0.040 |
Why?
|
| Factor VIIa | 1 | 1999 | 26 | 0.040 |
Why?
|
| Biopsy | 1 | 2007 | 3488 | 0.040 |
Why?
|
| Thromboplastin | 1 | 1999 | 33 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1999 | 68 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10400 | 0.040 |
Why?
|
| Male | 7 | 2020 | 128484 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 2019 | 93 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 14873 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 1999 | 82 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1999 | 100 | 0.040 |
Why?
|
| Carotid Artery, Common | 1 | 1999 | 91 | 0.040 |
Why?
|
| CHO Cells | 1 | 1999 | 320 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2019 | 107 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2020 | 245 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 883 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1998 | 101 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 12991 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 3657 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 1045 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 5102 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 931 | 0.040 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2023 | 838 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 5759 | 0.040 |
Why?
|
| Kinetics | 1 | 2000 | 2210 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 6258 | 0.030 |
Why?
|
| ROC Curve | 1 | 2020 | 1252 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2006 | 6343 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2019 | 822 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2019 | 490 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 7645 | 0.030 |
Why?
|
| Prognosis | 2 | 2020 | 22529 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 656 | 0.030 |
Why?
|
| Apoptosis | 1 | 2010 | 7755 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 14636 | 0.030 |
Why?
|
| Sulfones | 1 | 2015 | 145 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 10267 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 2142 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 153 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 1092 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 375 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 196 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 397 | 0.030 |
Why?
|
| Disease Progression | 1 | 2006 | 6868 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 1471 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 547 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1999 | 1306 | 0.030 |
Why?
|
| Base Sequence | 1 | 1999 | 5417 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 2492 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 491 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2013 | 91 | 0.030 |
Why?
|
| Animals | 4 | 2015 | 61554 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 6655 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 1512 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 15282 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 1459 | 0.020 |
Why?
|
| Triazoles | 1 | 2015 | 629 | 0.020 |
Why?
|
| Kidney | 1 | 1999 | 2105 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2007 | 17095 | 0.020 |
Why?
|
| Arginine | 1 | 2014 | 506 | 0.020 |
Why?
|
| Models, Biological | 1 | 2019 | 3189 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 1492 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 1684 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 722 | 0.020 |
Why?
|
| Risk Factors | 1 | 2007 | 17911 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 866 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2395 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 3110 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1197 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 3473 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3587 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 22293 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 702 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 3570 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 7320 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 5326 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2453 | 0.020 |
Why?
|
| Child | 1 | 2007 | 30596 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 33808 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 5692 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 4906 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2007 | 39951 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 2010 | 636 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 1715 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 1958 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 7054 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 2357 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 2189 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 5416 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1740 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3081 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 35477 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 31079 | 0.010 |
Why?
|